"Next-generation molecular technologies and validation tools for infectious diseases"

"New testing workflows for inherited disease and cancer clinical research"

October 24, 2012
9:00–10:00 a.m.

October 24, 2012
11:00 a.m–1:00 p.m.

103

In recent years, the use of molecular tests to diagnose infectious diseases has increased dramatically. Compared to older methods, the ability to accurately diagnose pathogens quickly, simply, and inexpensively is becoming a reality. Among the technologies for detecting a variety of organisms from clinical research specimens, sequencing and qPCR offer great promise. Attend our workshop and gain insight into how QuantStudio™ Dx real-time PCR*, Ion semiconductor sequencing technologies†, and EZValidation™ molecular validation and QC monitoring tools can help shape the future of your laboratory research.

* For Investigational Use Only. The performance characteristics of this product have not been established.

†For Research Use Only. Not for use in diagnostic procedures.

Cancer and inherited disease research using conventional molecular analysis has relied on the detection of single genes. But recognizing the complexity of the genes involved in these diseases has led to a new focus on multigene analysis and gene regulation. Attend our workshop and hear users of sequencing and real-time PCR platforms from Life Technologies describe how they test for inherited diseases and cancer in research samples. Technologies featured in the workshop include:

• Ion semiconductor sequencing*
• Ion AmpliSeq™ target selection*
• TaqMan® miRNA Assays*

Additionally, evidence to support the utility of the Pervenio ™ Lung RS** test in improving risk stratification of early-stage NSCLC patients toward better managing disease will be discussed.

*For Research Use Only. Not for use in diagnostic procedures.

**Laboratory developed test performed by the Life
Technologies CLIA-certified laboratory.